Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 4/2012

01-04-2012 | 2011 SSAT Quick Shot

15-Year Experience with Surgical Treatment of Duodenal Carcinoma: a Comparison of Periampullary and Extra-Ampullary Duodenal Carcinomas

Authors: Edwin O. Onkendi, Sarah Y. Boostrom, Michael G. Sarr, Michael B. Farnell, David M. Nagorney, John H. Donohue, Michael L. Kendrick, Kaye M. Reid-Lombardo, William S. Harmsen, Florencia G. Que

Published in: Journal of Gastrointestinal Surgery | Issue 4/2012

Login to get access

Abstract

Background

The aim of our study was to compare the outcomes of periampullary and extra-ampullary duodenal adenocarcinomas and segmental duodenal resection versus pancreatoduodenectomy and to evaluate prognostic factors.

Methods

We performed a retrospective review of all adults treated for duodenal adenocarcinoma by operative resection at a large tertiary referral center from 1994 to 2009.

Results

One hundred twenty-four patients had an operation for duodenal adenocarcinoma over a 15-year period (periampullary, n = 25, and extra-ampullary, n = 99). Ninety-nine patients (80%) underwent curative resection, including 24 (96%) with periampullary and 75 (76%) with extra-ampullary carcinomas. The average number of lymph nodes sampled was eight with segmental resection and 12 with pancreatoduodenectomy (p < 0.001). Five-year overall survivals were 37% for the entire cohort (n = 124), 37% in the extra-ampullary group, and 38% in the periampullary group. Tumor size (p = 0.20), positive nodes (p = 0.60), segmental resection versus pancreatoduodenectomy (p = 0.55), adjuvant therapy (p = 0.23), and R1 versus R0 resection (p = 0.21) were not associated with survival. In contrast, advanced T stage and pathologic grade were associated with poor survival.

Conclusion

Extra-ampullary and periampullary duodenal adenocarcinomas have similar survival after resection. For distal duodenal tumors, survival is improved by curative resection without being compromised by limited resection. The number of lymph nodes sampled was significantly less with segmental resection than pancreatoduodenectomy.
Literature
1.
go back to reference Struck A, Howard T, Chiorean EG, Clarke JM, Riffenburgh R, Cardenes HR (2009) Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival. J Surg Oncol 100:144–148PubMedCrossRef Struck A, Howard T, Chiorean EG, Clarke JM, Riffenburgh R, Cardenes HR (2009) Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival. J Surg Oncol 100:144–148PubMedCrossRef
2.
go back to reference Howe JR, Karnell LH, Menck HR, Scott-Conner C (1999) The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985–1995. Cancer 86:2693–2706PubMedCrossRef Howe JR, Karnell LH, Menck HR, Scott-Conner C (1999) The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985–1995. Cancer 86:2693–2706PubMedCrossRef
3.
go back to reference Sohn TA, Lillemoe KD, Cameron JL, Pitt HA, Kaufman HS, Hruban RH, Yeo CJ (1998) Adenocarcinoma of the duodenum: factors influencing long-term survival. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract 2:79–87CrossRef Sohn TA, Lillemoe KD, Cameron JL, Pitt HA, Kaufman HS, Hruban RH, Yeo CJ (1998) Adenocarcinoma of the duodenum: factors influencing long-term survival. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract 2:79–87CrossRef
4.
go back to reference Hurtuk MG, Devata S, Brown KM, Oshima K, Aranha GV, Pickleman J, Shoup M (2007) Should all patients with duodenal adenocarcinoma be considered for aggressive surgical resection? American journal of surgery 193:319–324; discussion 324–315PubMedCrossRef Hurtuk MG, Devata S, Brown KM, Oshima K, Aranha GV, Pickleman J, Shoup M (2007) Should all patients with duodenal adenocarcinoma be considered for aggressive surgical resection? American journal of surgery 193:319–324; discussion 324–315PubMedCrossRef
5.
go back to reference Bakaeen FG, Murr MM, Sarr MG, Thompson GB, Farnell MB, Nagorney DM, Farley DR, van Heerden JA, Wiersema LM, Schleck CD, Donohue JH (2000) What prognostic factors are important in duodenal adenocarcinoma? Arch Surg 135:635–641; discussion 641–632PubMedCrossRef Bakaeen FG, Murr MM, Sarr MG, Thompson GB, Farnell MB, Nagorney DM, Farley DR, van Heerden JA, Wiersema LM, Schleck CD, Donohue JH (2000) What prognostic factors are important in duodenal adenocarcinoma? Arch Surg 135:635–641; discussion 641–632PubMedCrossRef
6.
go back to reference Lee HG, You DD, Paik KY, Heo JS, Choi SH, Choi DW (2008) Prognostic factors for primary duodenal adenocarcinoma. World J Surg 32:2246–2252PubMedCrossRef Lee HG, You DD, Paik KY, Heo JS, Choi SH, Choi DW (2008) Prognostic factors for primary duodenal adenocarcinoma. World J Surg 32:2246–2252PubMedCrossRef
7.
go back to reference Pickleman J, Koelsch M, Chejfec G (1997) Node-positive duodenal carcinoma is curable. Archives of surgery 132:241–244PubMedCrossRef Pickleman J, Koelsch M, Chejfec G (1997) Node-positive duodenal carcinoma is curable. Archives of surgery 132:241–244PubMedCrossRef
8.
go back to reference Sexe RB, Wade TP, Virgo KS, Johnson FE (1996) Incidence and treatment of periampullary duodenal cancer in the U.S. veteran patient population. Cancer 77:251–254PubMedCrossRef Sexe RB, Wade TP, Virgo KS, Johnson FE (1996) Incidence and treatment of periampullary duodenal cancer in the U.S. veteran patient population. Cancer 77:251–254PubMedCrossRef
9.
go back to reference Wade TP, Coplin MA, Virgo KS, Johnson FE (1994) Periampullary cancer treatment in U.S. Department of Veterans Affairs hospitals: 1987–1991. Surgery 116:819–825; discussion 825–816PubMed Wade TP, Coplin MA, Virgo KS, Johnson FE (1994) Periampullary cancer treatment in U.S. Department of Veterans Affairs hospitals: 1987–1991. Surgery 116:819–825; discussion 825–816PubMed
10.
go back to reference Stell D, Mayer D, Mirza D, Buckels J (2004) Delayed diagnosis and lower resection rate of adenocarcinoma of the distal duodenum. Dig Surg 21:434–438; discussion 438–439PubMedCrossRef Stell D, Mayer D, Mirza D, Buckels J (2004) Delayed diagnosis and lower resection rate of adenocarcinoma of the distal duodenum. Dig Surg 21:434–438; discussion 438–439PubMedCrossRef
11.
go back to reference Lowell JA, Rossi RL, Munson JL, Braasch JW (1992) Primary adenocarcinoma of third and fourth portions of duodenum. Favorable prognosis after resection. Archives of surgery 127:557–560PubMedCrossRef Lowell JA, Rossi RL, Munson JL, Braasch JW (1992) Primary adenocarcinoma of third and fourth portions of duodenum. Favorable prognosis after resection. Archives of surgery 127:557–560PubMedCrossRef
12.
go back to reference Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of surgical oncology 17:1471–1474PubMedCrossRef Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of surgical oncology 17:1471–1474PubMedCrossRef
13.
go back to reference Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13PubMedCrossRef Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13PubMedCrossRef
14.
go back to reference Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, Neoptolemos JP, Padbury RT, Sarr MG, Traverso LW, Yeo CJ, Buchler MW (2007) Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 142:761–768PubMedCrossRef Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, Neoptolemos JP, Padbury RT, Sarr MG, Traverso LW, Yeo CJ, Buchler MW (2007) Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 142:761–768PubMedCrossRef
15.
go back to reference Ross WA, Bismar MM (2004) Evaluation and management of periampullary tumors. Curr Gastroenterol Rep 6:362–370PubMedCrossRef Ross WA, Bismar MM (2004) Evaluation and management of periampullary tumors. Curr Gastroenterol Rep 6:362–370PubMedCrossRef
16.
go back to reference Solej M, D'Amico S, Brondino G, Ferronato M, Nano M (2008) Primary duodenal adenocarcinoma. Tumori 94:779–786PubMed Solej M, D'Amico S, Brondino G, Ferronato M, Nano M (2008) Primary duodenal adenocarcinoma. Tumori 94:779–786PubMed
17.
go back to reference Tocchi A, Mazzoni G, Puma F, Miccini M, Cassini D, Bettelli E, Tagliacozzo S (2003) Adenocarcinoma of the third and fourth portions of the duodenum: results of surgical treatment. Archives of surgery 138:80–85PubMedCrossRef Tocchi A, Mazzoni G, Puma F, Miccini M, Cassini D, Bettelli E, Tagliacozzo S (2003) Adenocarcinoma of the third and fourth portions of the duodenum: results of surgical treatment. Archives of surgery 138:80–85PubMedCrossRef
18.
go back to reference Hu JX, Miao XY, Zhong DW, Dai WD, Liu W, Hu W (2006) Surgical treatment of primary duodenal adenocarcinoma. Hepato-gastroenterology 53:858–862PubMed Hu JX, Miao XY, Zhong DW, Dai WD, Liu W, Hu W (2006) Surgical treatment of primary duodenal adenocarcinoma. Hepato-gastroenterology 53:858–862PubMed
19.
go back to reference Ryder NM, Ko CY, Hines OJ, Gloor B, Reber HA (2000) Primary duodenal adenocarcinoma: a 40-year experience. Archives of surgery 135:1070–1074; discussion 1074–1075PubMedCrossRef Ryder NM, Ko CY, Hines OJ, Gloor B, Reber HA (2000) Primary duodenal adenocarcinoma: a 40-year experience. Archives of surgery 135:1070–1074; discussion 1074–1075PubMedCrossRef
20.
go back to reference Delcore R, Thomas JH, Forster J, Hermreck AS (1993) Improving resectability and survival in patients with primary duodenal carcinoma. American journal of surgery 166:626–630; discussion 630–621PubMedCrossRef Delcore R, Thomas JH, Forster J, Hermreck AS (1993) Improving resectability and survival in patients with primary duodenal carcinoma. American journal of surgery 166:626–630; discussion 630–621PubMedCrossRef
21.
go back to reference Barnes G, Jr., Romero L, Hess KR, Curley SA (1994) Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol 1:73–78PubMedCrossRef Barnes G, Jr., Romero L, Hess KR, Curley SA (1994) Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol 1:73–78PubMedCrossRef
22.
go back to reference Han SL, Cheng J, Zhou HZ, Zeng QQ, Lan SH (2010) The surgical treatment and outcome for primary duodenal adenocarcinoma. J Gastrointest Cancer 41:243–247PubMedCrossRef Han SL, Cheng J, Zhou HZ, Zeng QQ, Lan SH (2010) The surgical treatment and outcome for primary duodenal adenocarcinoma. J Gastrointest Cancer 41:243–247PubMedCrossRef
23.
go back to reference Kaklamanos IG, Bathe OF, Franceschi D, Camarda C, Levi J, Livingstone AS (2000) Extent of resection in the management of duodenal adenocarcinoma. Am J Surg 179:37–41PubMedCrossRef Kaklamanos IG, Bathe OF, Franceschi D, Camarda C, Levi J, Livingstone AS (2000) Extent of resection in the management of duodenal adenocarcinoma. Am J Surg 179:37–41PubMedCrossRef
24.
go back to reference Sarela AI, Brennan MF, Karpeh MS, Klimstra D, Conlon KC (2004) Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer. Annals of surgical oncology 11:380–386PubMedCrossRef Sarela AI, Brennan MF, Karpeh MS, Klimstra D, Conlon KC (2004) Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer. Annals of surgical oncology 11:380–386PubMedCrossRef
25.
go back to reference Joesting DR, Beart RW Jr, van Heerden JA, Weiland LH (1981) Improving survival in adenocarcinoma of the duodenum. Am J Surg 141:228–231PubMedCrossRef Joesting DR, Beart RW Jr, van Heerden JA, Weiland LH (1981) Improving survival in adenocarcinoma of the duodenum. Am J Surg 141:228–231PubMedCrossRef
Metadata
Title
15-Year Experience with Surgical Treatment of Duodenal Carcinoma: a Comparison of Periampullary and Extra-Ampullary Duodenal Carcinomas
Authors
Edwin O. Onkendi
Sarah Y. Boostrom
Michael G. Sarr
Michael B. Farnell
David M. Nagorney
John H. Donohue
Michael L. Kendrick
Kaye M. Reid-Lombardo
William S. Harmsen
Florencia G. Que
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 4/2012
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-011-1808-z

Other articles of this Issue 4/2012

Journal of Gastrointestinal Surgery 4/2012 Go to the issue